BridgeBio Neutral Stance From Citi Shakes ATTR-CM Outlook
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Nearing retirement at 50? Discover wealth management strategies tailored to secure your financial future effectively.
21,324 articlesCiti initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Target delivered a solid beat-and-raise quarter, yet shares slid, illustrating a sell-the-news dynamic. With Walmart ...
The 30-year treasury just crossed 5%, triggering a rotation from growth into asset-backed champions. This article fla...
Greg Abel is guiding Berkshire Hathaway into a strategic cleanup phase. Discover the two key exits reportedly tied to...
A bold policy idea could reshape how the U.S. handles digital assets. This article explains the proposed ARMA bill ai...
Federal prosecutors charged two men under a new anti-deepfake law for creating AI-generated nude images and videos th...
As Greg Abel steers Berkshire Hathaway's non-insurance businesses, Berkshire Hathaway Energy could emerge as a reliab...
Fairholme trimmed its stake in The St. Joe Company, but that doesn’t mean the stock isn’t worth a closer look. Here’s...
Meta Platforms delivered a strong Q1 with revenue eclipsing expectations while signaling heavier AI-driven capital ou...
Nasdaq’s Bitcoin options approval marks a regulatory milestone, paving the way for QBTC to trade inside the US option...
Regulators and crypto firms clash as debates over national bank charters intensify. This article breaks down what’s a...
The U.S. government is backing quantum startups with billions. Here’s how that move could affect stock selection, ris...